rs1042168

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001114134.2(EPB42):​c.330G>A​(p.Ala110Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0077 in 1,614,172 control chromosomes in the GnomAD database, including 644 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.036 ( 336 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 308 hom. )

Consequence

EPB42
NM_001114134.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.36

Publications

2 publications found
Variant links:
Genes affected
EPB42 (HGNC:3381): (erythrocyte membrane protein band 4.2) Erythrocyte membrane protein band 4.2 is an ATP-binding protein which may regulate the association of protein 3 with ankyrin. It probably has a role in erythrocyte shape and mechanical property regulation. Mutations in the EPB42 gene are associated with recessive spherocytic elliptocytosis and recessively transmitted hereditary hemolytic anemia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
EPB42 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 5
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 15-43215195-C-T is Benign according to our data. Variant chr15-43215195-C-T is described in ClinVar as Benign. ClinVar VariationId is 255153.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.36 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.119 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPB42NM_001114134.2 linkc.330G>A p.Ala110Ala synonymous_variant Exon 3 of 13 ENST00000441366.7 NP_001107606.1 P16452-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPB42ENST00000441366.7 linkc.330G>A p.Ala110Ala synonymous_variant Exon 3 of 13 1 NM_001114134.2 ENSP00000396616.2 P16452-1
EPB42ENST00000648595.1 linkc.420G>A p.Ala140Ala synonymous_variant Exon 3 of 13 ENSP00000497777.1 P16452-2
EPB42ENST00000540029.5 linkc.196+1073G>A intron_variant Intron 2 of 11 2 ENSP00000444699.1 F5H563
EPB42ENST00000569204.1 linkc.-7G>A upstream_gene_variant 3 ENSP00000455489.1 H3BPV8

Frequencies

GnomAD3 genomes
AF:
0.0363
AC:
5524
AN:
152162
Hom.:
334
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.122
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0118
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.0341
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000603
Gnomad OTH
AF:
0.0292
GnomAD2 exomes
AF:
0.0121
AC:
3040
AN:
251484
AF XY:
0.00984
show subpopulations
Gnomad AFR exome
AF:
0.120
Gnomad AMR exome
AF:
0.00434
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.0401
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000440
Gnomad OTH exome
AF:
0.00570
GnomAD4 exome
AF:
0.00471
AC:
6887
AN:
1461892
Hom.:
308
Cov.:
32
AF XY:
0.00429
AC XY:
3122
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.122
AC:
4098
AN:
33480
American (AMR)
AF:
0.00566
AC:
253
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00222
AC:
58
AN:
26136
East Asian (EAS)
AF:
0.0269
AC:
1066
AN:
39700
South Asian (SAS)
AF:
0.00344
AC:
297
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00728
AC:
42
AN:
5768
European-Non Finnish (NFE)
AF:
0.000239
AC:
266
AN:
1112012
Other (OTH)
AF:
0.0134
AC:
807
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
453
906
1358
1811
2264
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0364
AC:
5543
AN:
152280
Hom.:
336
Cov.:
32
AF XY:
0.0344
AC XY:
2564
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.122
AC:
5059
AN:
41532
American (AMR)
AF:
0.0118
AC:
180
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3470
East Asian (EAS)
AF:
0.0342
AC:
177
AN:
5182
South Asian (SAS)
AF:
0.00353
AC:
17
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000603
AC:
41
AN:
68024
Other (OTH)
AF:
0.0294
AC:
62
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
254
508
763
1017
1271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0140
Hom.:
156
Bravo
AF:
0.0416
Asia WGS
AF:
0.0440
AC:
154
AN:
3478
EpiCase
AF:
0.000709
EpiControl
AF:
0.000711

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary spherocytosis type 5 Benign:2
Aug 08, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
11
DANN
Benign
0.48
PhyloP100
-1.4
PromoterAI
-0.026
Neutral
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1042168; hg19: chr15-43507393; COSMIC: COSV55748750; COSMIC: COSV55748750; API